We measured the mRNA-expression of hepatocyte-nuclear-factor-4-alpha (HNF4A), which is a liver function marker that is correlated to a favorable outcome for HCC-patients (Hang et al., 2017). This evidence concerns the gene HNF4A and hepatocellular carcinoma.